Mezzion Pharma Co.,Ltd.
KOE: 140410.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Dong-Hyun Park
- Employees
- 18
- Headquarters
- Seoul, South Korea
- IPO year
- 2012
- Market cap
- ₩2.5T
- Website
- http://www.mezzion.co.kr
Loading 140410…
Loading profile data…Frequently asked questions about 140410
What does Mezzion Pharma Co.,Ltd. (140410.KQ) do?
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park, Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.
Where does 140410.KQ trade?
Mezzion Pharma Co.,Ltd. (140410.KQ) trades on the KOSDAQ.
What sector is 140410.KQ in?
Mezzion Pharma Co.,Ltd. (140410.KQ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Mezzion Pharma Co.,Ltd.?
Dong-Hyun Park is the chief executive officer of Mezzion Pharma Co.,Ltd. (140410.KQ).
Where is Mezzion Pharma Co.,Ltd. headquartered?
Mezzion Pharma Co.,Ltd. is headquartered in South Korea.
Does 140410.KQ pay a dividend?
Mezzion Pharma Co.,Ltd. (140410.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 140410.KQ go public?
Mezzion Pharma Co.,Ltd. (140410.KQ) completed its initial public offering in 2012.